{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:07Z","timestamp":1793214607393,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,30]],"date-time":"2014-05-30T00:00:00Z","timestamp":1401408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/eye.2014.110","type":"journal-article","created":{"date-parts":[[2014,5,30]],"date-time":"2014-05-30T09:40:24Z","timestamp":1401442824000},"page":"915-930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["The impact of new methods of investigation and treatment on the understanding of the pathology of scleral inflammation"],"prefix":"10.1038","volume":"28","author":[{"given":"P","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,30]]},"reference":[{"key":"BFeye2014110_CR1","first-page":"742","volume":"94","author":"J Wiiliamson","year":"1974","unstructured":"Wiiliamson J . Incidence of eye disease in cases of connective tissue disease. Trans Ophthal Soc UK 1974; 94: 742\u2013752.","journal-title":"Trans Ophthal Soc UK"},{"key":"BFeye2014110_CR2","doi-asserted-by":"publisher","DOI":"10.5005\/jp\/books\/11649","volume-title":"The Sclera and Systemic Disorders","author":"PG Watson","year":"2012","unstructured":"Watson PG, Hazleman BL, McKluskey P, Pavesio CE . The Sclera and Systemic Disorders 3rd edn. JP Medical: London, 2012."},{"key":"BFeye2014110_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-6502-8","volume-title":"The Sclera","author":"M Sainz de la Maza","year":"2012","unstructured":"Sainz de la Maza M, Tauber J, Foster CS . The Sclera 2nd edn Springer Verlag: New York, 2012."},{"issue":"2","key":"BFeye2014110_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","volume":"120","author":"WG Wieringa","year":"2013","unstructured":"Wieringa WG, Wieringa JE, ten Dam-van Loon NH, Los LI . Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmology 2013; 120 (2): 379\u2013386.","journal-title":"Ophthalmology"},{"issue":"3","key":"BFeye2014110_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0014-4835(03)00212-4","volume":"78","author":"PG Watson","year":"2004","unstructured":"Watson PG, Young RD . Scleral structure, organisation and disease. Exp Eye Res 2004; 78 (3): 609\u2013623.","journal-title":"Exp Eye Res"},{"key":"BFeye2014110_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.preteyeres.2013.02.004","volume":"35","author":"D Wakefield","year":"2013","unstructured":"Wakefield D, Di Girolamo N, Thurau S, Wildner G, McCluskey P . Scleritis: immunopathogenesis and molecular basis for therapy. Prog Retin Eye Res 2013; 35: 44\u201362.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"BFeye2014110_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/bjo.52.3.278","volume":"52","author":"PG Watson","year":"1968","unstructured":"Watson PG, Hayreh SS, Awdry PN . Episcleritis and scleritis. Brit J Ophthalmol 1968; 52 (3): 278\u2013279.","journal-title":"Brit J Ophthalmol"},{"issue":"7","key":"BFeye2014110_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/S0161-6420(99)00719-8","volume":"106","author":"WP Riono","year":"1999","unstructured":"Riono WP, Hidayat AA, Rao NA . Scleritis: a clinicopathologic study of 55 cases. Ophthalmology 1999; 106 (7): 1328\u20131333.","journal-title":"Ophthalmology"},{"issue":"11","key":"BFeye2014110_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/bies.201300084","volume":"35","author":"EM Paisson-McDermott","year":"2013","unstructured":"Paisson-McDermott EM, O\u2019Neill LA . The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays 2013; 35 (11): 965\u2013973.","journal-title":"Bioessays"},{"issue":"3","key":"BFeye2014110_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bjo.2007.126425","volume":"92","author":"Y Usui","year":"2008","unstructured":"Usui Y, Parikh J, Goto H, Rao NA . Immunopathology of necrotising scleritis. Br J Ophthalmol 2008; 92 (3): 417\u2013419.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"BFeye2014110_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.2130","volume":"16","author":"EF McKinney","year":"2010","unstructured":"McKinney EF, Lyons PA, Carr EJ, Hollis JL, Jayne DR, Willcocks LC et al. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. 2010 Nat Med 16 (5): 586\u2013591.","journal-title":"Nat Med"},{"key":"BFeye2014110_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/ni0107-11","volume":"8","author":"P Matzinger","year":"2007","unstructured":"Matzinger P . Friendly and danger signals:is the tissue in control? Nat Immunol 2007; 8: 11\u201313.","journal-title":"Nat Immunol"},{"key":"BFeye2014110_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nri2940","volume":"11","author":"P Matzinger","year":"2011","unstructured":"Matzinger P, Kamala T . Tissue based class control: the other side of tolerance. Nat Rev Immunol 2011; 11: 221\u2013230.","journal-title":"Nat Rev Immunol"},{"issue":"6147","key":"BFeye2014110_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1126\/science.1240342","volume":"341","author":"VO Millien","year":"2013","unstructured":"Millien VO, Lu W, Shaw J, Yuan X, Mak G, Roberts L et al. Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4. Science 2013; 341 (6147): 792\u2013796.","journal-title":"Science"},{"key":"BFeye2014110_CR15","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archopht.1979.01020020079019","volume":"97","author":"RM Hembry","year":"1979","unstructured":"Hembry RM, Playfair J, Watson PG, Dingle JT . Experimental model for scleritis. Arch Ophthalmol 1979; 97: 1337\u20131340.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"BFeye2014110_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/eye.1995.182","volume":"9","author":"GP Riley","year":"1995","unstructured":"Riley GP, Harrrall RL, Watson PG, Cawston TE, Hazleman BL . Collagenase (MMP1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye 1995; 9 (6): 703\u2013718.","journal-title":"Eye"},{"key":"BFeye2014110_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/eye.1988.104","volume":"2","author":"PR Meyer","year":"1988","unstructured":"Meyer PR . Patterns of blood flow in the episcleral vessels studied by low dose fluorescein angiography. Eye 1988; 2: 533\u2013536.","journal-title":"Eye"},{"key":"BFeye2014110_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1242\/jcs.74.1.95","volume":"74","author":"RD Young","year":"1985","unstructured":"Young RD . The ultrastructural organization of proteoglycans and collagen in human and rabbit scleral matrix. J Cell Sci 1985; 74: 95\u2013104.","journal-title":"J Cell Sci"},{"key":"BFeye2014110_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0014-4835(65)80052-5","volume":"4","author":"D Maurice","year":"1965","unstructured":"Maurice D, Watson PG . The distribution and movement of serum albumin in the cornea. Exp Eye Res 1965; 4: 355\u2013336.","journal-title":"Exp Eye Res"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2014110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2014110","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2014110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:21:41Z","timestamp":1684430501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2014110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,30]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFeye2014110"],"URL":"https:\/\/doi.org\/10.1038\/eye.2014.110","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,30]]},"assertion":[{"value":"20 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Peter Watson declares no conflict of interest. Andre Romano is a consultant for Optovue, Inc. and has received research support from them.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}